Obesity Drugs Reveal Power of First Impressions: Marriage, Employment Rise for Single Women

The power of first impressions in social and economic outcomes, particularly for women, may be significantly influenced by weight loss achieved through new obesity medications, according to a study by Stanford University economics professor Rebecca Diamond.

Her research, utilizing the "Understanding America Study" survey, found that single women who used glucagon-like peptide-1 (GLP-1) agonists for weight loss were more likely to marry or begin cohabitating within 18 months compared to a control group. Similarly, women who were unemployed before starting the medication saw a significant increase in their likelihood of finding employment.

Diamond explained that these changes likely stem from how initial perceptions influence crucial life decisions like choosing a partner or applying for jobs. The study focused solely on women due to insufficient GLP-1 user numbers among men for statistical analysis. The findings were published as a working paper by the National Bureau of Economic Research (NBER), meaning they have not yet undergone peer review.

“

Simply being more motivated would have improved these indicators, but that wasn't the case. We believe that first impressions may have had a greater impact.

While previous research has linked weight to marriage and employment, isolating weight's impact has been challenging due to confounding factors like health and economic conditions. GLP-1 drugs offer a unique research opportunity, enabling the tracking of social and economic changes before and after significant weight loss within the same individuals.

However, the study did not find significant improvements in mood or life satisfaction that would fully explain the increase in relationships or employment. This suggests that the "first impression" effect, driven by changes in appearance, played a more substantial role than enhanced confidence or mood alone. The research also noted that women already married or employed before using the drugs showed no significant changes, implying that established relationships and professional reputations may mitigate the impact of weight changes.

“

If others are losing weight and even gaining employment opportunities, but those who cannot afford the medication are left behind, the stigma against overweight people could worsen.